#1012, Yale — New Haven, Connecticut

#1012, Yale is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

#1012, Yale has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: Debiopharm International SA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for #1012, Yale?

#1012, Yale has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has #1012, Yale conducted?

#1012, Yale has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor.

Is #1012, Yale accredited by Crixeo Health?

#1012, Yale has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about #1012, Yale?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.